Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation.
Tembo G, Mayuni M, Kamng'ona R, Chimgoneko L, Chiwala G, Sichone S, Galafa B, Thole F, Mkandawire C, Chirwa AE, Nsomba E, Nkhoma V, Ngoliwa C, Toto N, Makhaza L, Muyaya A, Kudowa E, Henrion MYR, Dula D, Morton B, Chikaonda T, Gordon SB, Jambo KC. Tembo G, et al. Among authors: kamng ona r. Vaccine. 2024 Apr 30;42(12):2975-2982. doi: 10.1016/j.vaccine.2024.03.055. Epub 2024 Apr 4. Vaccine. 2024. PMID: 38570270 Free PMC article.
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study.
Dula D, Morton B, Chikaonda T, Chirwa AE, Nsomba E, Nkhoma V, Ngoliwa C, Sichone S, Galafa B, Tembo G, Chaponda M, Toto N, Kamng'ona R, Makhaza L, Muyaya A, Thole F, Kudowa E, Howard A, Kenny-Nyazika T, Ndaferankhande J, Mkandawire C, Chiwala G, Chimgoneko L, Banda NPK, Rylance J, Ferreira D, Jambo K, Henrion MYR, Gordon SB; Malawi Accelerated Research in Vaccines, Experimental and Laboratory Systems (MARVELS) consortium. Dula D, et al. Among authors: kamng ona r. Lancet Microbe. 2023 Sep;4(9):e683-e691. doi: 10.1016/S2666-5247(23)00178-7. Lancet Microbe. 2023. PMID: 37659418 Free PMC article. Clinical Trial.
Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population.
Doherty K, Dula D, Chirwa A, Nsomba E, Nkhoma VS, Toto N, Chikaonda T, Kamng'ona R, Phiri J, Reiné J, Ndaferankhande J, Makhaza L, Banda P, Jambo K, Ferreira DM, Gordon SB. Doherty K, et al. Among authors: kamng ona r. Wellcome Open Res. 2024 Jan 3;9:2. doi: 10.12688/wellcomeopenres.19949.1. eCollection 2024. Wellcome Open Res. 2024. PMID: 38362541 Free PMC article.
High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi.
Chibwana MG, Jere KC, Kamn'gona R, Mandolo J, Katunga-Phiri V, Tembo D, Mitole N, Musasa S, Sichone S, Lakudzala A, Sibale L, Matambo P, Kadwala I, Byrne RL, Mbewe A, Henrion MYR, Morton B, Phiri C, Mallewa J, Mwandumba HC, Adams ER, Gordon SB, Jambo KC. Chibwana MG, et al. medRxiv [Preprint]. 2020 Aug 5:2020.07.30.20164970. doi: 10.1101/2020.07.30.20164970. medRxiv. 2020. PMID: 32766597 Free PMC article. Updated. Preprint.
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles.
Morton B, Barnes KG, Anscombe C, Jere K, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda N, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC. Morton B, et al. Among authors: kamng ona r. medRxiv [Preprint]. 2021 Feb 20:2021.02.15.21251753. doi: 10.1101/2021.02.15.21251753. medRxiv. 2021. Update in: Nat Commun. 2021 Jun 11;12(1):3554. doi: 10.1038/s41467-021-23267-w PMID: 33619502 Free PMC article. Updated. Preprint.
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa.
Morton B, Barnes KG, Anscombe C, Jere K, Matambo P, Mandolo J, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda NP, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB; Blantyre COVID-19 Consortium; Cornick J, Jambo KC. Morton B, et al. Among authors: kamng ona r. Nat Commun. 2021 Jun 11;12(1):3554. doi: 10.1038/s41467-021-23267-w. Nat Commun. 2021. PMID: 34117221 Free PMC article.
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.
Chibwana MG, Moyo-Gwete T, Kwatra G, Mandolo J, Hermanaus T, Motlou T, Mzindle N, Ayres F, Chaponda M, Tembo G, Mwenechanya P, Mitole N, Jassi C, Kamng'ona R, Afran L, Mzinza D, Mwandumba HC, Gordon SB, Jere K, Madhi S, Moore PL, Heyderman RS, Jambo KC. Chibwana MG, et al. Among authors: kamng ona r. BMC Med. 2022 Mar 28;20(1):128. doi: 10.1186/s12916-022-02342-z. BMC Med. 2022. PMID: 35346184 Free PMC article.
Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi.
Mseka UL, Mandolo J, Nyoni K, Divala O, Kambalame D, Mapemba D, Kamzati M, Chibwe I, Henrion MYR, Manda K, Thindwa D, Mvula M, Odala B, Kamng'ona R, Dzinza N, Jere KC, Feasey N, Ho A, Amoah AS, Gordon M, Swarthout TD, Crampin A, Heyderman RS, Kagoli M, Chitsa-Banda E, Mitambo C, Phuka J, Chilima B, Kasambara W, Jambo KC, Chauma-Mwale A. Mseka UL, et al. Among authors: kamng ona r. EClinicalMedicine. 2023 Feb;56:101800. doi: 10.1016/j.eclinm.2022.101800. Epub 2022 Dec 30. EClinicalMedicine. 2023. PMID: 36600885 Free PMC article.
18 results